Literature DB >> 15809086

Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers.

Guangwen Wang1, Hong Zhang, Yang Zhao, Jian Li, Jun Cai, Peigang Wang, Sha Meng, Jingbo Feng, Chenglin Miao, Mingxiao Ding, Dongsheng Li, Hongkui Deng.   

Abstract

Human embryonic stem (hES) cells are typically maintained on mouse embryonic fibroblast (MEF) feeders or with MEF-conditioned medium. However, these xenosupport systems greatly limit the therapeutic applications of hES cells because of the risk of cross-transfer of animal pathogens. Here we showed that the bone morphogenetic protein antagonist noggin is critical in preventing differentiation of hES cells in culture. Furthermore, we found that the combination of noggin and basic fibroblast growth factor (bFGF) was sufficient to maintain the prolonged growth of hES cells while retaining all hES cell features. Since both noggin and bFGF are expressed in MEF, our findings suggest that they may be important factors secreted by MEF for maintaining undifferentiated pluripotent hES cells. Our data provide new insight into the mechanism how hES cell self-renewal is regulated. The newly developed feeder-free culture system will provide a more reliable alternative for future therapeutic applications of hES cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809086     DOI: 10.1016/j.bbrc.2005.03.058

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  64 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

2.  Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions.

Authors:  Shuyuan Yao; Shuibing Chen; Julie Clark; Ergeng Hao; Gillian M Beattie; Alberto Hayek; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

3.  A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo.

Authors:  Lorraine Iacovitti; Angela E Donaldson; Cheryl E Marshall; Sokreine Suon; Ming Yang
Journal:  Brain Res       Date:  2006-11-21       Impact factor: 3.252

4.  Human embryonic stem cell (hES) colonies display a higher degree of spontaneous differentiation when passaged at lower densities.

Authors:  Boon Chin Heng; Hua Liu; Abdul Jalil Rufaihah; Tong Cao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

Review 5.  The pursuit of ES cell lines of domesticated ungulates.

Authors:  Neil C Talbot; Le Ann Blomberg
Journal:  Stem Cell Rev       Date:  2008-07-09       Impact factor: 5.739

Review 6.  Pluripotent stem cell lines.

Authors:  Junying Yu; James A Thomson
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

Review 7.  Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency.

Authors:  Morag H Stewart; Sean C Bendall; Mickie Bhatia
Journal:  J Mol Med (Berl)       Date:  2008-06-03       Impact factor: 4.599

8.  Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging.

Authors:  Mohammad Pakzad; Mehdi Totonchi; Adeleh Taei; Ali Seifinejad; Seyedeh Nafiseh Hassani; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

9.  BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway.

Authors:  Hao Bai; Yongxing Gao; Melanie Arzigian; Don M Wojchowski; Wen-Shu Wu; Zack Z Wang
Journal:  J Cell Biochem       Date:  2010-02-01       Impact factor: 4.429

Review 10.  Targeting stem cells-clinical implications for cancer therapy.

Authors:  Lan Chun Tu; Greg Foltz; Edward Lin; Leroy Hood; Qiang Tian
Journal:  Curr Stem Cell Res Ther       Date:  2009-05       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.